Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antithymocyte Globulin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00857389
What this trial is testing

Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies

Who this might be right for
Stem Cell TransplantationLeukemiaLymphoma
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)UnknownNCT04778618
What this trial is testing

Individualized Dose Study of ATG in Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Haploidentical Hematopoietic Stem Cell Transplantation
Chinese PLA General Hospital 63
Testing effectiveness (Phase 2)Study completedNCT00278525
What this trial is testing

Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma

Who this might be right for
SYSTEMIC SCLERODERMA
Northwestern University 19
Testing effectiveness (Phase 2)Looking for participantsNCT06984536
What this trial is testing

Reduced ATG Plus Mini PTCy for GVHD Prophylaxis in Haplo-SCT

Who this might be right for
Myelodysplastic SyndromeAcute Leukemia
Peking University People's Hospital 40
Not applicableStudy completedNCT04835948
What this trial is testing

Efficacy of Single Dose Anti-thymocyte Globulin in the Modulation of T Lymphocytes in Kidney Transplantation

Who this might be right for
Kidney Transplant; ComplicationsImmunosuppression
Hospital de Clinicas de Porto Alegre 200
Testing effectiveness (Phase 2)Study completedNCT00278538
What this trial is testing

Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus Erythematosus

Who this might be right for
Systemic Lupus Erythematosus
Northwestern University 32
Post-approval studies (Phase 4)Study completedNCT01883180
What this trial is testing

ATG in Haploidentical HSCT for Acute Graft-versus-host Disease Prophylaxis

Who this might be right for
Hematopoietic Stem Cell TransplantationAntithymocyte GlobulinViral Infection
Nanfang Hospital, Southern Medical University 412
Very early researchUnknownNCT03292445
What this trial is testing

Inducing Graft Tolerance in HLA Haplotype Matched Related and 3 Ag Matched Unrelated Living Donor Kidney Transplantation

Who this might be right for
Immune Tolerance
Samuel Strober 24
Testing effectiveness (Phase 2)Study completedNCT01168219
What this trial is testing

Busulfan, Fludarabine Phosphate, and Anti-Thymocyte Globulin Followed By Donor Stem Cell Transplant and Azacitidine in Treating Patients With High-Risk Myelodysplastic Syndrome and Older Patients With Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid LeukemiaAdult Acute Megakaryoblastic LeukemiaAdult Acute Monoblastic Leukemia+17 more
National Cancer Institute (NCI) 68
Early research (Phase 1)UnknownNCT01165762
What this trial is testing

Combined Blood Stem Cell and Kidney Transplant of One Haplotype Match Living Donor Pairs.

Who this might be right for
ESRD
Everett Meyer 25
Testing effectiveness (Phase 2)Study completedNCT00627666
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematological Cancer

Who this might be right for
LeukemiaMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative Neoplasms
Asan Medical Center 52
Testing effectiveness (Phase 2)Ended earlyNCT00593645
What this trial is testing

Clofarabine, Cytarabine, and Thymoglobulin for Allogeneic Transplantation

Who this might be right for
Myelodysplastic SyndromesAcute Myeloid Leukemia
Washington University School of Medicine 7
Not applicableStudy completedNCT01265537
What this trial is testing

A Pilot Study Comparing the Use of Low-target Versus Conventional Target Advagraf

Who this might be right for
Acute Graft RejectionDiabetes
University of British Columbia 30
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Testing effectiveness (Phase 2)UnknownNCT00882323
What this trial is testing

Reduced Toxicity Fludarabine (Flu) + Cyclophosphamide (CPM) + Rabbit Antithymocyte Globulin (rATG) Conditioning Regimen for Unrelated Donor Transplantation in Severe Aplastic Anemia (SAA)

Who this might be right for
Aplastic Anemia
The Korean Society of Pediatric Hematology Oncology 33
Large-scale testing (Phase 3)Study completedNCT02099747
What this trial is testing

HATG+CsA vs hATG+CsA+Eltrombopag for SAA

Who this might be right for
Severe Aplastic Anemia
European Society for Blood and Marrow Transplantation 202
Not applicableActive Not RecruitingNCT06039020
What this trial is testing

ATGAM General Investigation

Who this might be right for
Aplastic Anemia
Pfizer 1
Not applicableEnded earlyNCT02428517
What this trial is testing

Allogeneic Hematopoietic Cell Transplantation for Adult Acute Lymphoblastic Leukemia (2015)

Who this might be right for
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Asan Medical Center 20
Testing effectiveness (Phase 2)Ended earlyNCT00482053
What this trial is testing

Phase 2 Poor Risk DLBCL of TLI and ATG Followed by Matched Allogeneic HT as Consolidation to Autologous HCT

Who this might be right for
Lymphoma, B-cellLymphoma, Non-HodgkinDiffuse Large B-cell Lymphoma (DLBCL)+1 more
Stanford University 3
Testing effectiveness (Phase 2)Study completedNCT01413100
What this trial is testing

Scleroderma Treatment With Autologous Transplant (STAT) Study

Who this might be right for
Systemic Scleroderma
Fred Hutchinson Cancer Center 21
Next Page